Andrew Bush
National Institutes of Health
996 Papers
5.3K Citations
Andrew Bush is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Medicine & Asthma. The author has an hindex of 99, co-authored 935 publications. Previous affiliations of Andrew Bush include Imperial College London & University of Tennessee Health Science Center.
Chat about Author
Papers
Thorax: the prostate years.
Ian D. Pavord,Andrew Bush +1 more
TL;DR: Thorax had a good 2013, cementing its position as the second-ranked respiratory journal behind the American Journal of Respiratory and Critical Care Medicine and reflecting a reduction in original articles published per edition with the introduction of new content published in the ‘Chest Clinic’ section.
Comparison ofthehaemodynamic effects of epoprostenol (prostacyclin) andtolazoline
Andrew Bush,C M Busst,W B Knight,E A Shinebourne +3 more
- 01 Jan 1988
TL;DR: Epoprostenol is suggested to be a more suitable pulmonary vasodilator if more than a single dose is required, and tolazoline didn't have anaclinically important haemodynamic advantage over epoprostinol, according to the 95% confidence intervals.
P80 Extrapolating lung clearance index (LCI) from shortened measurements
TL;DR: LCIex performed better than LCI0.5 in predicting results of LCIstd, and LCIex was also sensitive to interventions in asthmatic and CF patients, although in general LCI std had better p values.
WS23.4 High Rhinovirus burden in lower airways of children with cystic fibrosis
Elisabeth Kieninger,Florian Singer,C. Tapparel,Marco P. Alves,Philipp Latzin,Hui-Leng Tan,Cara Bossley,Carmen Casaulta,Andrew Bush,Jane C. Davies,L. Kaiser,Nicolas Regamey +11 more
TL;DR: Progression of lung disease within specific genotypes of patients with cystic fibrosis (CF) − Which lung function parameter differentiates best?